631 related articles for article (PubMed ID: 20100866)
21. Interactome analysis reveals that C1QBP (complement component 1, q subcomponent binding protein) is associated with cancer cell chemotaxis and metastasis.
Zhang X; Zhang F; Guo L; Wang Y; Zhang P; Wang R; Zhang N; Chen R
Mol Cell Proteomics; 2013 Nov; 12(11):3199-209. PubMed ID: 23924515
[TBL] [Abstract][Full Text] [Related]
22. ITGB2-mediated metabolic switch in CAFs promotes OSCC proliferation by oxidation of NADH in mitochondrial oxidative phosphorylation system.
Zhang X; Dong Y; Zhao M; Ding L; Yang X; Jing Y; Song Y; Chen S; Hu Q; Ni Y
Theranostics; 2020; 10(26):12044-12059. PubMed ID: 33204328
[No Abstract] [Full Text] [Related]
23. Mitochondrial fission induces glycolytic reprogramming in cancer-associated myofibroblasts, driving stromal lactate production, and early tumor growth.
Guido C; Whitaker-Menezes D; Lin Z; Pestell RG; Howell A; Zimmers TA; Casimiro MC; Aquila S; Ando' S; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Oncotarget; 2012 Aug; 3(8):798-810. PubMed ID: 22878233
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial p32 is a critical mediator of ARF-induced apoptosis.
Itahana K; Zhang Y
Cancer Cell; 2008 Jun; 13(6):542-53. PubMed ID: 18538737
[TBL] [Abstract][Full Text] [Related]
25. Anti-mitochondrial therapy in human breast cancer multi-cellular spheroids.
Mandujano-Tinoco EA; Gallardo-Pérez JC; Marín-Hernández A; Moreno-Sánchez R; Rodríguez-Enríquez S
Biochim Biophys Acta; 2013 Mar; 1833(3):541-51. PubMed ID: 23195224
[TBL] [Abstract][Full Text] [Related]
26. The mitospecific domain of Mrp7 (bL27) supports mitochondrial translation during fermentation and is required for effective adaptation to respiration.
Anderson JM; Box JM; Stuart RA
Mol Biol Cell; 2022 Jan; 33(1):ar7. PubMed ID: 34731012
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial p32/C1QBP is highly expressed in prostate cancer and is associated with shorter prostate-specific antigen relapse time after radical prostatectomy.
Amamoto R; Yagi M; Song Y; Oda Y; Tsuneyoshi M; Naito S; Yokomizo A; Kuroiwa K; Tokunaga S; Kato S; Hiura H; Samori T; Kang D; Uchiumi T
Cancer Sci; 2011 Mar; 102(3):639-47. PubMed ID: 21205079
[TBL] [Abstract][Full Text] [Related]
28. Enhanced liver but not muscle OXPHOS in diabetes and reduced glucose output by complex I inhibition.
Alimujiang M; Yu XY; Yu MY; Hou WL; Yan ZH; Yang Y; Bao YQ; Yin J
J Cell Mol Med; 2020 May; 24(10):5758-5771. PubMed ID: 32253813
[TBL] [Abstract][Full Text] [Related]
29. Role of C1QBP/p32 and its Therapeutic Potential in Breast Carcinoma and other Cancers.
Matsumoto K; Bay BH
Curr Med Chem; 2021; 28(25):5048-5065. PubMed ID: 33390103
[TBL] [Abstract][Full Text] [Related]
30. Lactate-mediated mitoribosomal defects impair mitochondrial oxidative phosphorylation and promote hepatoma cell invasiveness.
Lee YK; Lim JJ; Jeoun UW; Min S; Lee EB; Kwon SM; Lee C; Yoon G
J Biol Chem; 2017 Dec; 292(49):20208-20217. PubMed ID: 28978646
[TBL] [Abstract][Full Text] [Related]
31. Elevated Heme Synthesis and Uptake Underpin Intensified Oxidative Metabolism and Tumorigenic Functions in Non-Small Cell Lung Cancer Cells.
Sohoni S; Ghosh P; Wang T; Kalainayakan SP; Vidal C; Dey S; Konduri PC; Zhang L
Cancer Res; 2019 May; 79(10):2511-2525. PubMed ID: 30902795
[TBL] [Abstract][Full Text] [Related]
32. Oxygen consumption can regulate the growth of tumors, a new perspective on the Warburg effect.
Chen Y; Cairns R; Papandreou I; Koong A; Denko NC
PLoS One; 2009 Sep; 4(9):e7033. PubMed ID: 19753307
[TBL] [Abstract][Full Text] [Related]
33. Lactic acidosis switches cancer cells from aerobic glycolysis back to dominant oxidative phosphorylation.
Wu H; Ying M; Hu X
Oncotarget; 2016 Jun; 7(26):40621-40629. PubMed ID: 27259254
[TBL] [Abstract][Full Text] [Related]
34. Focal adhesion kinase-promoted tumor glucose metabolism is associated with a shift of mitochondrial respiration to glycolysis.
Zhang J; Gao Q; Zhou Y; Dier U; Hempel N; Hochwald SN
Oncogene; 2016 Apr; 35(15):1926-42. PubMed ID: 26119934
[TBL] [Abstract][Full Text] [Related]
35. Double genetic disruption of lactate dehydrogenases A and B is required to ablate the "Warburg effect" restricting tumor growth to oxidative metabolism.
Ždralević M; Brand A; Di Ianni L; Dettmer K; Reinders J; Singer K; Peter K; Schnell A; Bruss C; Decking SM; Koehl G; Felipe-Abrio B; Durivault J; Bayer P; Evangelista M; O'Brien T; Oefner PJ; Renner K; Pouysségur J; Kreutz M
J Biol Chem; 2018 Oct; 293(41):15947-15961. PubMed ID: 30158244
[TBL] [Abstract][Full Text] [Related]
36. Inhibiting neddylation modification alters mitochondrial morphology and reprograms energy metabolism in cancer cells.
Zhou Q; Li H; Li Y; Tan M; Fan S; Cao C; Meng F; Zhu L; Zhao L; Guan MX; Jin H; Sun Y
JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30668548
[TBL] [Abstract][Full Text] [Related]
37. The mitochondrial protein C1qbp promotes cell proliferation, migration and resistance to cell death.
McGee AM; Douglas DL; Liang Y; Hyder SM; Baines CP
Cell Cycle; 2011 Dec; 10(23):4119-27. PubMed ID: 22101277
[TBL] [Abstract][Full Text] [Related]
38. Fascin Controls Metastatic Colonization and Mitochondrial Oxidative Phosphorylation by Remodeling Mitochondrial Actin Filaments.
Lin S; Huang C; Gunda V; Sun J; Chellappan SP; Li Z; Izumi V; Fang B; Koomen J; Singh PK; Hao J; Yang S
Cell Rep; 2019 Sep; 28(11):2824-2836.e8. PubMed ID: 31509745
[TBL] [Abstract][Full Text] [Related]
39. Extension of chronological life span by reduced TOR signaling requires down-regulation of Sch9p and involves increased mitochondrial OXPHOS complex density.
Pan Y; Shadel GS
Aging (Albany NY); 2009 Jan; 1(1):131-45. PubMed ID: 20157595
[TBL] [Abstract][Full Text] [Related]
40. Targeting Oxidative Phosphorylation Reverses Drug Resistance in Cancer Cells by Blocking Autophagy Recycling.
Lee JS; Lee H; Jang H; Woo SM; Park JB; Lee SH; Kang JH; Kim HY; Song J; Kim SY
Cells; 2020 Sep; 9(9):. PubMed ID: 32883024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
